申请人:Hoffmann-La Roche Inc.
公开号:US20150218144A1
公开(公告)日:2015-08-06
The invention is concerned with the compounds of formula (I):
and pharmaceutically acceptable salts thereof, wherein Y, R1, R2 and R3 are defined in the detailed description and claims. In addition, the present invention relates to methods of manufacturing and using the compounds of formula (I) as well as pharmaceutical compositions containing such compounds. The compounds of formula (I) are antagonists of the TRPA1 channel and may be useful in treating inflammatory diseases and disorders associated with that channel.
本发明涉及式(I)的化合物及其药学上可接受的盐,其中Y、R1、R2和R3在详细描述和权利要求中有定义。此外,本发明还涉及制造和使用式(I)化合物的方法以及含有这些化合物的药物组合物。式(I)的化合物是TRPA1通道拮抗剂,可能在治疗与该通道相关的炎症性疾病和紊乱方面有用。